Cancer Management and Research
Subject Area | Rank | Percentile |
---|---|---|
Category: Medicine Subcategory: Oncology |
91 / 404 |
APC | APC Waiver | Other Charges |
---|---|---|
Yes: Check details ( USD2990; ) | Yes: Check details | No |
Quartiles By JIF | Collection | Quartile | Rank | Percentage |
Category: ONCOLOGY | SCIE | Q3 | 183/322 |
|
Quartiles By JCI | Collection | Quartile | Rank | Percentage |
Category: ONCOLOGY | SCIE | Q3 | 178/322 |
|
Journal Title | h-index | CiteScore |
---|---|---|
Nature Cancer | 0 | 31.10 |
JAMA Oncology | 41 | 37.50 |
JAMA Oncology | 61 | 37.50 |
Trends in Cancer | 0 | 28.50 |
Liver Cancer | 25 | 20.80 |
Experimental Hematology & Oncology | 0 | 12.60 |
ESMO Open | 0 | 11.70 |
Cancer Biology & Medicine | 29 | 9.80 |
Annual Review of Cancer Biology | 0 | 14.50 |
Cancers | 53 | 8.00 |
Select your rating and start your review of Cancer Management and Research
2024-06-21
Review speed: 6.0 | Submission acceptance rate: 95.0
Emphasized research directions: Oncology; Chronic disease management; Sharing of oncology rehabilitation experiences: Impact factor for 2023 is 2.5 points.
2024-04-29
It's really slow, keep asking for the raw data
2024-04-24
Received
2024-04-09
It is not convenient to contact co-authors, you often have to send emails to each author and need each author to confirm. Also, it has been 3 weeks since the initial review, finding reviewers is also very slow. When submitting to another journal, ONCOtarget and therapy, after a month and a half, we couldn't find reviewers and had to withdraw the submission
2024-03-12
The period is just two or three months
2024-03-11
So excellent!
2024-02-27
4A in rework
2024-02-19
What is your current status now?
2024-01-22
1.22 or 2b..., is still only one reviewer, this is too slow, despair
2024-01-21
How valuable, currently 1A 3 weeks ?